scispace - formally typeset
S

Sheng-Jiun Wu

Researcher at Janssen Pharmaceutica

Publications -  63
Citations -  1098

Sheng-Jiun Wu is an academic researcher from Janssen Pharmaceutica. The author has contributed to research in topics: Epitope & Antibody. The author has an hindex of 17, co-authored 61 publications receiving 959 citations. Previous affiliations of Sheng-Jiun Wu include University of Pennsylvania.

Papers
More filters
Journal ArticleDOI

Structure-based engineering of a monoclonal antibody for improved solubility

TL;DR: Adding an N-linked carbohydrate to the CDR was the most effective route for enhancing the solubility of CNTO607, and the consensus N-glycosylation site in H-CDR2 was reintroduced which was found in the original antibody.
Journal ArticleDOI

Structural Basis for the Dual Recognition of IL-12 and IL-23 by Ustekinumab

TL;DR: Interestingly, this structure also reveals significant structural differences in the p35 subunit and p35/p40 interface, compared with the published crystal structure of human IL-12, suggesting unusual and potentially functionally relevant structural flexibility of p35, as well as p40/p35 recognition.
Journal ArticleDOI

Cross-Interaction Chromatography: A Rapid Method to Identify Highly Soluble Monoclonal Antibody Candidates

TL;DR: Retention times of the antibodies tested were found to be inversely related to solubility, with antibodies prone to precipitate at low concentrations in PBS being retained longer on the columns with broader peaks.
Journal ArticleDOI

Mechanisms of self-association of a human monoclonal antibody CNTO607.

TL;DR: The results provide direct support for the aggregation model that CNTO607 precipitation results primarily from the specific interaction of the Fab arms of neighboring antibodies followed by the development of an extensive network of antibodies inducing large-scale aggregation and precipitation.
Journal ArticleDOI

Epitope mapping and structural basis for the recognition of phosphorylated tau by the anti-tau antibody AT8.

TL;DR: The phosphoepitope of AT8 was characterized through both peptide binding studies and costructures with phosphopeptides, and it was shown that AT8 bound to the triply phosphorylated tau peptide 30‐fold stronger than to the pS202/pT205 peptide, supporting the role of pS208 in AT8 recognition.